Open Vial News Today

Bharat biotech: Bharat Biotech seeks nod for phase-3 trials of intranasal Covid-19 vaccine as booster dose | India News - Rashtra News : Rashtra News #bharat #biotech #Bharat #Biotech #seeks #nod #phase3 #trials #intranasal #Covid19 #vaccine #booster #dose #India #News #Times #India HYDERABAD: Bharat Biotech has sought the Drug Controller General of India's approval to

Bharat Biotech has sought the Drug Controller General of India's approval to conduct phase-3 trials of its intranasal vaccine (BBV154) against Covid to be used as a booster dose, sources said on Monday.

Hyderabad, December 20 Bharat Biotech has sought the Drug Controller General of India's approval to conduct phase-3 trials of its Covid-19 intranasal vaccine (BBV154) to use as booster dose, sources